At an estimated value of over USD 10.98 billion in 2019, the Global Acne Medication Market
is predicted to thrive at a CAGR of 3.1% and valued at over USD 15.36 billion over the
forecast year 2020-2030.
Acne is the most common skin conditions typically caused by changes in structures of the
skin. It affects almost millions of adolescents around the globe. Hence, there is huge
demand for topical as well as oral acne medication. Topical medication includes creams,
gels, and ointments that consist of retinoids, benzoyl peroxide, salicylic acid, and others. On
the other hand, oral acne medication is relatively more effective where moderate to severe
acne do not respond to topical agents.
Access Full Description of this report at:-
Top Companies: Almirall SA., Bausch Health Companies Inc., Galderma S.A, Mayne Pharma
Group Limited, GlaxoSmithKline Plc (GSK), Mylan N.V., Pfizer Inc., Johnson & Johnson, Sun
Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd and others.
The global acne medication market share is segmented on the basis of therapeutic class,
formulation, type, acne type, distribution channel, and geography. On the basis of
therapeutic class, the market is categorized into retinoids, antibiotics, benzoyl peroxide,
salicylic acid, and others. According to the formulation, the market is segmented into topical
medications and oral medications. As per the type, the market is divided into prescription
medicines and over-the-counter medicines. On the basis of acne type, the market is divided
into non-inflammatory acne and inflammatory acne. As per the distribution channel, it is
categorized as retail stores, e-commerce, and pharmacies & drug stores.
Request sample copy of this report at:-
In terms of geography, North America held major share of the market in 2019. This is
attributed to the surge in use of skin care products and increased awareness abou